SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Canaccord Genuity Sets $18 Price Target for Tonix Pharmaceuticals

Canaccord Genuity initiated coverage of Tonix Pharmaceuticals at Buy, according to the body.

TNXP

Related stories